Valuation : Principal Technologies Inc.

Market Cap 18.08M 13.07M 11.24M 10.58M 9.66M 1.23B 18.13M 125M 48.51M 633M 49.07M 48M 2.04B P/E 2024 *
-
P/E 2025 -2x
Enterprise Value 17.08M 12.34M 10.62M 9.99M 9.13M 1.17B 17.12M 118M 45.82M 598M 46.35M 45.34M 1.93B EV / Sales 2024
7,172,726x
EV / Sales 2025 25,290,400x
Free-Float
66.21%
Yield 2024 *
-
Yield 2025 -
3 years 0
Extreme 0
0.27
5 years 0
Extreme 0
0.27
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 47 04/08/2021
Director of Finance/CFO 70 06/03/2023
Director TitleAgeSince
Director/Board Member 70 04/08/2021
Chairman 55 -
Director/Board Member 47 04/08/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 14.81M
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average -0.83%+0.53%+74.05%+109.63% 30.55B
Weighted average by Cap. -1.03%+0.11%+89.42%+127.93%

Financials

2024 2025
Net sales 0.66 0.48 0.41 0.39 0.35 45.31 0.67 4.59 1.78 23.25 1.8 1.76 74.9 0.37 0.27 0.23 0.22 0.2 25.28 0.37 2.56 0.99 12.97 1.01 0.98 41.78
Net income -1.62M -1.17M -1M -945K -863K -110M -1.62M -11.17M -4.33M -56.55M -4.38M -4.29M -182M -4.24M -3.06M -2.63M -2.48M -2.26M -289M -4.25M -29.29M -11.36M -148M -11.5M -11.24M -478M
Net Debt -767K -555K -477K -449K -410K -52.37M -770K -5.31M -2.06M -26.87M -2.08M -2.04M -86.56M -1M -725K -624K -587K -536K -68.45M -1.01M -6.94M -2.69M -35.12M -2.72M -2.66M -113M
Logo Principal Technologies Inc.
Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Employees
-